Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.

van Mello NM, Mol F, Verhoeve HR, van Wely M, Adriaanse AH, Boss EA, Dijkman AB, Bayram N, Emanuel MH, Friederich J, van der Leeuw-Harmsen L, Lips JP, Van Kessel MA, Ankum WM, van der Veen F, Mol BW, Hajenius PJ.

Hum Reprod. 2013 Jan;28(1):60-7. doi: 10.1093/humrep/des373. Epub 2012 Oct 18.

PMID:
23081873
2.

The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.

van Mello NM, Mol F, Adriaanse AH, Boss EA, Dijkman AB, Doornbos JP, Emanuel MH, Friederich J, Leeuw-Harmsen Lv, Lips JP, van Santbrink EJ, Verhoeve HR, Visser H, Ankum WM, Veen Fv, Mol BW, Hajenius PJ.

BMC Womens Health. 2008 Jun 19;8:10. doi: 10.1186/1472-6874-8-10.

3.

Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management.

van Mello NM, Mol F, Hajenius PJ, Ankum WM, Mol BW, van der Veen F, van Wely M.

Eur J Obstet Gynecol Reprod Biol. 2015 Sep;192:1-5. doi: 10.1016/j.ejogrb.2015.06.007. Epub 2015 Jun 17.

PMID:
26125101
4.

Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.

Casikar I, Lu C, Reid S, Bignardi T, Mongelli M, Morris A, Wild R, Condous G.

Rev Recent Clin Trials. 2012 Aug;7(3):238-43. Review.

PMID:
22540910
5.

Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.

Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ.

Hum Reprod. 2016 Feb;31(2):332-8. doi: 10.1093/humrep/dev312. Epub 2015 Dec 23.

PMID:
26701971
6.

How feasible is expectant management of interstitial ectopic pregnancy?

Poon LC, Emmanuel E, Ross JA, Johns J.

Ultrasound Obstet Gynecol. 2014 Mar;43(3):317-21. doi: 10.1002/uog.12565. Epub 2014 Feb 12.

7.

Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.

Wu J, Ludlow JP, De Vries B, Black K, Beale P.

Aust N Z J Obstet Gynaecol. 2014 Oct;54(5):469-74. doi: 10.1111/ajo.12247.

PMID:
25287564
8.

Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels.

Guha S, Ayim F, Ludlow J, Sayasneh A, Condous G, Kirk E, Stalder C, Timmerman D, Bourne T, Van Calster B.

Hum Reprod. 2014 May;29(5):938-45. doi: 10.1093/humrep/deu045. Epub 2014 Mar 14.

PMID:
24634251
9.

Diagnostic accuracy of varying discriminatory zones for the prediction of ectopic pregnancy in women with a pregnancy of unknown location.

Condous G, Kirk E, Lu C, Van Huffel S, Gevaert O, De Moor B, De Smet F, Timmerman D, Bourne T.

Ultrasound Obstet Gynecol. 2005 Dec;26(7):770-5.

10.

Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.

Bonin L, Pedreiro C, Moret S, Chene G, Gaucherand P, Lamblin G.

Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:23-30. doi: 10.1016/j.ejogrb.2016.11.016. Epub 2016 Nov 19.

PMID:
27888702
11.

Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy.

Krissi H, Hiersch L, Stolovitch N, Nitke S, Wiznitzer A, Peled Y.

Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:172-6. doi: 10.1016/j.ejogrb.2014.09.026. Epub 2014 Sep 27.

PMID:
25300059
12.

Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.

Saraj AJ, Wilcox JG, Najmabadi S, Stein SM, Johnson MB, Paulson RJ.

Obstet Gynecol. 1998 Dec;92(6):989-94.

PMID:
9840564
13.

Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.

Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ.

Hum Reprod Update. 2008 Jul-Aug;14(4):309-19. doi: 10.1093/humupd/dmn012. Epub 2008 Jun 2. Review.

PMID:
18522946
14.

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.

Nowak-Markwitz E, Michalak M, Olejnik M, Spaczynski M.

Fertil Steril. 2009 Oct;92(4):1203-7. doi: 10.1016/j.fertnstert.2008.07.1775. Epub 2008 Oct 11.

PMID:
18851850
15.
16.

Conservative management of tubal ectopic pregnancy.

van Mello NM, Mol F, Mol BW, Hajenius PJ.

Best Pract Res Clin Obstet Gynaecol. 2009 Aug;23(4):509-18. doi: 10.1016/j.bpobgyn.2008.12.007. Epub 2009 Mar 19.

PMID:
19299204
17.

Treatment of ectopic pregnancy with methotrexate.

Kasum M, Oresković S, Simunić V, Jezek D, Tomić V, Tomić J, Gall V, Mihaljević S.

Acta Clin Croat. 2012 Dec;51(4):543-8.

PMID:
23540161
18.

Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management.

Kirk E, Van Calster B, Condous G, Papageorghiou AT, Gevaert O, Van Huffel S, De Moor B, Timmerman D, Bourne T.

Acta Obstet Gynecol Scand. 2011 Mar;90(3):264-72. doi: 10.1111/j.1600-0412.2010.01053.x. Epub 2011 Jan 13.

PMID:
21306315
19.

Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study.

Helmy S, Mavrelos D, Sawyer E, Ben-Nagi J, Koch M, Day A, Jurkovic D.

PLoS One. 2015 Jul 2;10(7):e0130598. doi: 10.1371/journal.pone.0130598. eCollection 2015.

20.

The clinical performance of the M4 decision support model to triage women with a pregnancy of unknown location as at low or high risk of complications.

Bobdiwala S, Guha S, Van Calster B, Ayim F, Mitchell-Jones N, Al-Memar M, Mitchell H, Stalder C, Bottomley C, Kothari A, Timmerman D, Bourne T.

Hum Reprod. 2016 Jul;31(7):1425-35. doi: 10.1093/humrep/dew105. Epub 2016 May 10.

Supplemental Content

Support Center